Breast cancer is the most common cancer among women, annually more than half a million women were diagnosed with breast cancer. Trastuzumab (Herceptin®) is a recombinant DNA-derived humanized monoclonal antibody used in the treatment of metastatic breast cancer. A course of treatment, however, is very expensive and a full one-year course of treatment for ...